|
Astorg, a leading European private equity firm, is pleased to announce that it has signed an agreement to acquire a majority stake in Avania (or the "Company") from Kester Capital ("Kester").
Avania is one of the leading global clinical CROs ("Contract Research Organisation") dedicated to medical technology. Astorg, alongside Kester who intend to retain a minority stake, will actively support management's plans to accelerate Avania's development, organically and through MA.
Avania is one of the leading global providers of outsourced clinical trial services specifically focused on medical technology, covering the full regulatory lifecycle across a broad range of therapeutic areas. Headquartered in the Netherlands, and with eight offices across...
|